Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries

Biological/cell based
General health
Online since 16 April 2024, updated 51 days ago

About this trial

Autologous Incubated Macrophages (ProCord) is being developed as a therapy for acute, complete spinal cord injury (SCI). The therapy is intended to reverse the loss of motor and sensory function. Fol...

Included participants

Gender
All
Age
16 - 65 years
Injury level
C5 - T11
  • Severity (AIS)?
  • AIS-A
    Time since injury
    ≤ 14 days
  • Injury type
  • Traumatic

    Healthy volunteers
    No
    C5-T11

    What’s involved

    Type

    Biological/cell based

    Details

    There are no details yet

    Potential benefits

    Main benefits

    General health

    Additional benefits

    Bladder health/function

    Bowel health

    Sensory function

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Ended
    • Trial start date
    • 1 Sep 2003
    • Organisation
    • Proneuron Biotechnologies
    • Trial recruitment status
    • Ended
    • Trial start date
    • 1 Sep 2003
    • Organisation
    • Proneuron Biotechnologies

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more